Back to search

Carleton University

Characterizing Aptamer-Based Alpha-Synuclein Fibril Inhibitors as a Potential Therapeutic Agent of Parkinson's Disease

Abstract

dc:description.abstract

With predominant focus on the role of the protein α-synuclein, given its increased tendency to form neurotoxic oligomeric and fibril species, this thesis investigates aptamers as a Parkinson's Disease (PD) therapeutic generated specifically for the detection and inhibition of monomeric α-synuclein. Aptamers are single stranded oligonucleotide sequences designed for the recognition of target structures with high affinity and selectivity. Binding affinity and conformation analysis of five aptamer sequences, ASYN(1-5), for monomeric α-synuclein were evaluated through various detection methods. ASYN2, having the highest affinity for monomeric α-synuclein, discriminated against similarly structured proteins, preferentially binding with monomeric α-synuclein. ASYN2 truncations, exploiting potential binding domains within the aptamer, yielded six minimer sequences labelled A2m(1-6). Fibril inhibition assays determined both ASYN2 and A2m3 displayed inhibition potential at 1:1 molar ratios of aptamer to protein. Further investigation into ASYN2 and A2m3 could reveal its application as a PD therapeutic.

Degree

thesis:*
Name thesis:degree_name
Master of Science (M.Sc.)
Level thesis:degree_level
Master's
Discipline thesis:degree_discipline
Chemistry
Grantor dc:publisher
Carleton University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Boisjoli, Spencer Frederick

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • Copyright © 2020 the author(s). Theses may be used for non-commercial research, educational, or related academic purposes only. Such uses include personal study, research, scholarship, and teaching. Theses may only be shared by linking to Carleton University Institutional Repository and no part may be used without proper attribution to the author. No part may be used for commercial purposes directly or indirectly via a for-profit platform; no adaptation or derivative works are permitted without consent from the copyright owner.
Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Carleton University
Base URL
carleton.scholaris.ca/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Boisjoli, Spencer Frederick. Characterizing Aptamer-Based Alpha-Synuclein Fibril Inhibitors as a Potential Therapeutic Agent of Parkinson's Disease. Master's thesis, Carleton University, 2020. https://hdl.handle.net/20.500.14718/42014